Természetes hatóanyagok jelentőségének vizsgálata máj- és ...

40. Chiba, K., Kubota, E., Miyakawa, T., Kato, Y., Ishizaki, T.: Characterization of
hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine
in mice. J. Pharmacol. Exp. Ther. 1988, 246, 1108-
1115.
41. Chieli, E., Mavaldi, G.: Role of microsomal FAD-containing monooxygenase in liver
toxicity of thioacetamide-S-oxide. Toxicology 1984, 31, 45-52.
42. Childs, J.F.L., Siegler, E.A.: Uses of thioacetamide in agriculture. Science (Wash
DC)1945, 102, 68-72.
43. Chung, F.L., Schwartz, J., Herzog, C.R., Yang, Y.M.: Tea and cancer prevention:
studies in animals and humans. J. Nutr. 2003, 133, 3268-3274.
44. Cinti, D.L., Moldeus, P., Schenkman, J.B.: Kinetic parameters of drug-metabolizing
enzymes in Ca 2+ sedimented microsomes from rat liver. Biochem. Pharmacol. 1972, 21,
3249-3256.
45. Ciolino, H.P., Wang, T.T., Yeh, G.C.: Diosmin and diosmetin are agonists of the aryl
hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer
Res. 1998, 58, 2754-2760.
46. Clemetson, C.A.B., Andersen: Plant polyphenols as antioxidants for ascorbic acid.
Ann. N.Y. Acad. Sci. 1966, 136, 339-378.
47. Cortez-Pinto, H., Camilo, E.M.: Non-alcoholic fatty liver disease/non-alcoholic
steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract. Res. Cl. Ga.,
2004, 18, 1089-1104.
48. Cospite, M.: Double-blind, placebo-controlled evaluation of clinical activity and
safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology. 1994, 45,
566-573.
49. Cova, D., De Angelis, L., Giavarini, F., Palladini, G., Perego, R.: Pharmacokinetics
and metabolism of oral diosmin in healthy volunteers. Inter. J. Clin. Pharmacol. Ther.
Toxicol. 1992, 30, 29-33.
50. Crespo, M.E., Galvez, J., Cruz, T. Ocete, M.A., Zarzuelo, A.: Anti-inflammatory
activity of diosmin and hesperidin in rat colitis induced by TNBS. Planta Med. 1999, 65,
651-653.
51. Cypriani, B., Limasset, B., Carrie, M.L., Le Doucen, C., Roussie, M., de Paulet, A.C.,
Damon, M.: Antioxidant activity of micronized diosmin on oxygen species from
stimulated human neutrophils. Biochem. Pharmacol. 1993, 45, 1531-1535.
52. Damon, M., Flandre, O., Michel, F., Perdrix, L., Labrid, C., Crastes de Paulet, A.:
Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma
in the rat. Study of prostaglandin E2 and F2 alpha and thromboxane B2 release and
histological changes. Arzneimittelforschung. 1987, 37, 1149-1153.
53. Dannan, G.A., Guengerich, F.P., Waxman, D.J.: Hormonal regulation of rat liver
microsomal enzymes: Role of gonadal steroids in programming, maintenance, and
suppression of 4-steroid 5 -reductase, flavin-containing monooxygenase, and sexspecific
cytochromes P-450. J Biol Chem 1986, 261, 10728-10735.
54. Daniel, P.T., Holzschuh, J., Berg, P.A.: The pathogenesis of cianidol-induced fever.
Eur. J. Clin. Pharm., 1988, 34, 241–247.
55. De-Ferreyra, E.C., De-Fenos, O.M. Castro, J.A.: Prevention of thioacetamide-induced
liver necrosis by prior administration of substrates of microsomal flavin-containing
monooxygenases. Toxicol. Lett. 1983, 18, 127-131.
56. Deutsches Arzneibuch, Amtliche Ausgabe (DAB 10). Deutscher Apotheker Verlag,
Stuttgart, Govi-Verlag GmbH, Frankfurt a.m. /Eschborn, Germany, 1996.
57. Diez-Fernandez, C., Sanz, N., Alvarez, A.M., Zaragoza, A., Cascales, M.: Influence
of aminoguanidine on parameters of kiver injury and regeneration induced in rats by a
necrogenic dose of thioacetamide. Br. J. Pharmacol. 1998, 125, 102-108.
58. Directive 2004/24/EC of the European Parliament and of the Council of 31 March
2004
134